Market Tracker

08/24 5:16pm ET

Endocyte Inc (NASDAQ:ECYT)

3.10
Delayed Data
As of Aug 24
 -0.17 / -5.20%
Today’s Change
2.65
Today|||52-Week Range
5.70
-22.69%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close3.27
Today’s open3.25
Day’s range2.98 - 3.38
Volume310,330
Average volume (3 months)152,242
Market cap$138.2M
Dividend yield--
Data as of 3:59pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-14.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.80

Competitors

 Today’s
change
Today’s
% change
PRQRProQR Therapeutics N...-0.13-2.19%
FBIOFortress Biotech Inc-0.06-2.13%
ADHDAlcobra Ltd-0.10-1.98%
EIGREiger BioPharmaceuti...-0.11-0.66%
Data as of 3:59pm ET, 08/24/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts